#BEGIN_DRUGCARD DB08249

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H38O6

# Chemical_IUPAC_Name:
3,6,9,12,15-pentaoxatricosan-1-ol

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:30:12 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3,6,9,12,15-PENTAOXATRICOSAN-1-OL

# HET_ID:
N8E

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H38O6/c1-2-3-4-5-6-7-9-20-11-13-22-15-17-24-18-16-23-14-12-21-10-8-19/h19H,2-18H2,1H3

# InChI_Key:
InChIKey=MJELOWOAIAAUJT-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8255

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
350.4907

# Molecular_Weight_Mono:
350.266838948

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.43

# Predicted_LogS:
-4.6

# Predicted_Water_Solubility:
8.58e-03 g/l

# Primary_Accession_No:
DB08249

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
159866

# PubChem_Substance_ID:
99444720

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCCCCCCOCCOCCOCCOCCOCCO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:37 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Mitochondrion
mitochondrial inner membrane

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
DHODH

# Drug_Target_1_GenBank_ID_Gene:
M94065

# Drug_Target_1_GenBank_ID_Protein:
555594

# Drug_Target_1_GeneCard_ID:
DHODH

# Drug_Target_1_Gene_Name:
DHODH

# Drug_Target_1_Gene_Sequence:
>1191 bp
AAATTACCGTGGAGACACCTGCAAAAGCGGGCCCAGGATGCTGTGATCATCCTGGGGGGA
GGAGGACTTCTCTTCGCCTCCTACCTGATGGCCACGGGAGATGAGCGTTTCTATGCTGAA
CACCTGATGCCGACTCTGCAGGGGCTGCTGGACCCGGAGTCAGCCCACAGACTGGCTGTT
CGCTTCACCTCCCTGGGGCTCCTTCCACGGGCCAGATTTCAAGACTCTGACATGCTGGAA
GTGAGAGTTCTGGGCCATAAATTCCGAAATCCAGTAGGAATTGCTGCAGGATTTGACAAG
CATGGGGAAGCCGTGGACGGACTTTATAAGATGGGCTTTGGTTTTGTTGAGATAGGAAGT
GTGACTCCAAAACCTCAGGAAGGAAACCCTAGACCCAGAGTCTTCCGCCTCCCTGAGGAC
CAAGCTGTCATTAACAGGTATGGATTTAACAGTCACGGGCTTTCAGTGGTGGAACACAGG
TTACGGGCCAGACAGCAGAAGCAGGCCAAGCTCACAGAAGATGGACTGCCTCTGGGGGTC
AACTTGGGGAAGAACAAGACCTCAGTGGACGCCGCGGAGGACTACGCAGAAGGGGTGCGC
GTACTGGGCCCCCTGGCCGACTACCTGGTGGTGAATGTGTCCAGCCCCAACACTGCCGGG
CTGCGGAGCCTTCAGGGAAAGGCCGAGCTGCGCCGCCTGCTGACCAAGGTGCTGCAGGAG
AGGGATGGCTTGCGGAGAGTGCACAGGCCGGCAGTCCTGGTGAAGATCGCTCCTGACCTC
ACCAGCCAGGATAAGGAGGACATTGCCAGTGTGGTCAAAGAGTTGGGCATCGATGGGCTG
ATTGTTACGAACACCACCGTGAGTCGCCCTGCGGGCCTCCAGGGTGCCCTGCGCTCTGAA
ACAGGAGGGCTGAGTGGGAAGCCCCTCCGGGATTTATCAACTCAAACCATTCGGGAGATG
TATGCACTCACCCAAGGCCGAGTTCCCATAATTGGGGTTGGTGGTGTGAGCAGCGGGCAG
GACGCGCTGGAGAAGATCCGGGCAGGGGCCTCCCTGGTGCAGCTGTACACGGCCCTCACC
TTCTGGGGGCCACCCGTTGTGGGCAAAGTCAAGCGGGAACTGGAGGCCCTTCTGAAAGAG
CAGGGCTTTGGCGGAGTCACAGATGCCATTGGAGCAGATCATCGGAGGTGA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
1446837	Minet M, Dufour ME, Lacroute F: Cloning and sequencing of a human cDNA coding for dihydroorotate dehydrogenase by complementation of the corresponding yeast mutant. Gene. 1992 Nov 16;121(2):393-6.

# Drug_Target_1_HGNC_ID:
HGNC:2867

# Drug_Target_1_HPRD_ID:
00521

# Drug_Target_1_ID:
424

# Drug_Target_1_Locus:
16q22

# Drug_Target_1_Molecular_Weight:
42868

# Drug_Target_1_Name:
Dihydroorotate dehydrogenase, mitochondrial

# Drug_Target_1_Number_of_Residues:
395

# Drug_Target_1_PDB_ID:
1D3H

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01180	DHO_dh

# Drug_Target_1_Protein_Sequence:
>Dihydroorotate dehydrogenase, mitochondrial precursor
MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVR
FTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSV
TPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVN
LGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQER
DGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSET
GGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTF
WGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR

# Drug_Target_1_Reaction:
(S)-dihydroorotate + O2 = orotate + H2O2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q02127

# Drug_Target_1_SwissProt_Name:
PYRD_HUMAN

# Drug_Target_1_Synonyms:
DHOdehase
Dihydroorotate dehydrogenase, mitochondrial precursor
Dihydroorotate oxidase
EC 1.3.3.1

# Drug_Target_1_Theoretical_pI:
10.23

# Drug_Target_1_Transmembrane_Regions:
13-32

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
D10390

# Drug_Target_2_GenBank_ID_Protein:
391839

# Drug_Target_2_GeneCard_ID:
fadB

# Drug_Target_2_Gene_Name:
fadB

# Drug_Target_2_Gene_Sequence:
>2148 bp
ATGATTTACGAAGGTAAAGCCATCACGGTTACGGCTCTTGAAAGTGGCATCGTCGAACTG
AAGTTCGACCTCAAGGGTGAGTCCGTCAACAAATTCAACCGTCTAACCCTGAACGAATTG
CGTCAGGCGGTAGATGCGATCAAGGCCGACGCTTCGGTCAAGGGTGTCATCGTTTCCAGC
GGTAAAGACGTATTTATCGTCGGCGCCGACATCACCGAATTCGTCGAAAACTTCAAGTTG
CCGGATGCCGAGCTGATTGCTGGCAACCTCGAAGCCAACAAGATCTTCAGCGATTTTGAA
GACCTCAATGTACCCACCGTCGCAGCCATCAATGGCATCGCGTTGGGCGGTGGCCTGGAA
ATGTGCCTGGCAGCCGACTTCCGGGTCATGGCCGACAGCGCCAAGATCGGCCTGCCGGAA
GTCAAACTGGGCATCTACCCGGGCTTTGGCGGCACCGTACGTCTGCCACGCCTGATCGGT
GTTGATAACGCGGTTGAGTGGATTGCCTCCGGCAAGGAAAACCGCGCAGAAGACGCTCTG
AAAGTCAGCGCCGTTGATGCTGTTGTCACTGCTGACAAGCTGGGCGCAGCTGCCCTGGAC
CTGATCAAGCGCGCCATCAGTGGCGAACTGGACTACAAGGCCAAGCGTCAGCCGAAGCTG
GAAAAACTCAAGCTCAACGCTATCGAACAAATGATGGCTTTCGAAACCGCCAAAGGTTTC
GTGGCTGGCCAGGCCGGCCCGAACTACCCGGCCCCGGTTGAAGCGATCAAGACCATCCAG
AAAGCCGCGAACTTCGGTCGTGACAAAGCCCTGGAAGTGGAAGCTGCAGGTTTCGCCAAG
CTGGCCAAAACCAGCGCCTCGAACTGCCTGATCGGCCTGTTCCTGAACGATCAGGAACTG
AAGAAAAAGGCCAAGGTCTACGACAAGATCGCCAAAGACGTGAAGCAGGCCGCCGTTCTG
GGCGCCGGCATCATGGGTGGCGGCATTGCCTATCAGTCGGCGTCCAAAGGCACGCCGATC
CTGATGAAGGACATCAACGAGCACGGTATCGAGCAGGGCCTGGCTGAAGCCGCCAAGCTG
CTGGTAGGTCGCGTTGATAAAGGTCGCATGACCCCGGCAAAAATGGCTGAAGTGCTGAAC
GGCATTCGTCCTACTCTGTCCTACGGCGATTTCGGCAACGTCGACCTGGTGGTCGAAGCG
GTTGTCGAGAACCCGAAGGTCAAGCAGGCCGTGTTGGCGGAAGTGGAAAACCACGTTCGC
GAAGACGCCATCCTCGCTTCCAACACCTCGACCATTTCCATCAGCTTGCTGGCCAAGGCC
CTCAAGCGTCCGGAAAACTTCGTCGGCATGCACTTCTTCAACCCGGTACACATGATGCCG
CTGGTTGAAGTGATCCGTGGCGAGAAGTCCAGCGACCTGGCCGTGGCCACCACCGTTGCC
TACGCCAAGAAAATGGGCAAGAACCCGATCGTGGTCAACGACTGCCCGGGCTTCCTGGTC
AACCGCGTACTGTTCCCGTACTTCGGCGGTTTCGCCAAGCTGGTCAGCGCCGGTGTCGAC
TTTGTGCGTATCGACAAAGTGATGGAAAAATTCGGCTGGCCGATGGGCCCGGCGTACCTG
ATGGACGTGGTCGGTATCGACACTGGCCACCACGGTCGCGACGTGATGGCTGAAGGCTTC
CCGGACCGCATGAAAGACGACCGCCGCTCGGCGATCGATGCGCTGTACGAGGCCAAGCGC
CTGGGTCAGAAGAACGGCAAGGGCTTCTACGCCTACGAGGCTGACAAAAAGGGCAAGCAG
AAGAAACTGGTTGATTCGAGCGTGCTTGAAGTGCTCAAACCAATCGTTTACGAGCAGCGC
GACGTGACCGACGAAGACATCATCAACTGGATGATGATCCCGCTGTGCCTGGAAACCGTG
CGTTGCCTGGAAGACGGTATCGTTGAAACTGCAGCCGAGGCCGATATGGGCCTGGTCTAC
GGCATTGGCTTCCCGCTGTTCCGTGGTGGCGCGCTGCGCTACATCGATTCGATCGGTGTT
GCAGAGTTCGTCGCCCTGGCCGATCAGTACGCTGAACTGGGCGCGCTGTACCACCCGACT
GCGAAGCTGCGTGAGATGGCCAAGAACGGCCAGAGCTTCTTCGGTTAA

# Drug_Target_2_General_Function:
Lipid transport and metabolism

# Drug_Target_2_General_References:
15229654	Ishikawa M, Tsuchiya D, Oyama T, Tsunaka Y, Morikawa K: Structural basis for channelling mechanism of a fatty acid beta-oxidation multienzyme complex. EMBO J. 2004 Jul 21;23(14):2745-54. Epub 2004 Jul 1.
1607366	Sato S, Hayashi M, Imamura S, Ozeki Y, Kawaguchi A: Primary structures of the genes, faoA and faoB, from Pseudomonas fragi B-0771 which encode the two subunits of the HDT multienzyme complex involved in fatty acid beta-oxidation. J Biochem. 1992 Jan;111(1):8-15.
8206878	Sato S, Ozeki Y, Kawaguchi A: Transcription of the faoAB operon which encodes the HDT multienzyme complex involved in fatty acid beta-oxidation in Pseudomonas fragi B-0771. J Biochem. 1994 Feb;115(2):286-92.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6764

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
77136.7

# Drug_Target_2_Name:
Fatty acid oxidation complex subunit alpha

# Drug_Target_2_Number_of_Residues:
715

# Drug_Target_2_PDB_ID:
1WDM

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00378	ECH
PF00725	3HCDH
PF02737	3HCDH_N

# Drug_Target_2_Protein_Sequence:
>Fatty acid oxidation complex subunit alpha
MIYEGKAITVTALESGIVELKFDLKGESVNKFNRLTLNELRQAVDAIKADASVKGVIVSS
GKDVFIVGADITEFVENFKLPDAELIAGNLEANKIFSDFEDLNVPTVAAINGIALGGGLE
MCLAADFRVMADSAKIGLPEVKLGIYPGFGGTVRLPRLIGVDNAVEWIASGKENRAEDAL
KVSAVDAVVTADKLGAAALDLIKRAISGELDYKAKRQPKLEKLKLNAIEQMMAFETAKGF
VAGQAGPNYPAPVEAIKTIQKAANFGRDKALEVEAAGFAKLAKTSASNCLIGLFLNDQEL
KKKAKVYDKIAKDVKQAAVLGAGIMGGGIAYQSASKGTPILMKDINEHGIEQGLAEAAKL
LVGRVDKGRMTPAKMAEVLNGIRPTLSYGDFGNVDLVVEAVVENPKVKQAVLAEVENHVR
EDAILASNTSTISISLLAKALKRPENFVGMHFFNPVHMMPLVEVIRGEKSSDLAVATTVA
YAKKMGKNPIVVNDCPGFLVNRVLFPYFGGFAKLVSAGVDFVRIDKVMEKFGWPMGPAYL
MDVVGIDTGHHGRDVMAEGFPDRMKDDRRSAIDALYEAKRLGQKNGKGFYAYEADKKGKQ
KKLVDSSVLEVLKPIVYEQRDVTDEDIINWMMIPLCLETVRCLEDGIVETAAEADMGLVY
GIGFPLFRGGALRYIDSIGVAEFVALADQYAELGALYHPTAKLREMAKNGQSFFG

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes the formation of an hydroxyacyl-CoA by addition of water on enoyl-CoA. Also exhibits 3-hydroxyacyl-CoA epimerase and 3-hydroxyacyl-CoA dehydrogenase activities (By similarity)

# Drug_Target_2_SwissProt_ID:
P28793

# Drug_Target_2_SwissProt_Name:
FADB_PSEFR

# Drug_Target_2_Synonyms:
3-hydroxyacyl-CoA dehydrogenase
Enoyl-CoA hydratase/Delta(3)-cis-Delta(2)-trans-enoyl-CoA isomerase/3-hydroxybutyryl-CoA epimerase

# Drug_Target_2_Theoretical_pI:
6.05

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm (By similarity)

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
D10390

# Drug_Target_3_GenBank_ID_Protein:
391839

# Drug_Target_3_GeneCard_ID:
fadA

# Drug_Target_3_Gene_Name:
fadA

# Drug_Target_3_Gene_Sequence:
>2148 bp
ATGATTTACGAAGGTAAAGCCATCACGGTTACGGCTCTTGAAAGTGGCATCGTCGAACTG
AAGTTCGACCTCAAGGGTGAGTCCGTCAACAAATTCAACCGTCTAACCCTGAACGAATTG
CGTCAGGCGGTAGATGCGATCAAGGCCGACGCTTCGGTCAAGGGTGTCATCGTTTCCAGC
GGTAAAGACGTATTTATCGTCGGCGCCGACATCACCGAATTCGTCGAAAACTTCAAGTTG
CCGGATGCCGAGCTGATTGCTGGCAACCTCGAAGCCAACAAGATCTTCAGCGATTTTGAA
GACCTCAATGTACCCACCGTCGCAGCCATCAATGGCATCGCGTTGGGCGGTGGCCTGGAA
ATGTGCCTGGCAGCCGACTTCCGGGTCATGGCCGACAGCGCCAAGATCGGCCTGCCGGAA
GTCAAACTGGGCATCTACCCGGGCTTTGGCGGCACCGTACGTCTGCCACGCCTGATCGGT
GTTGATAACGCGGTTGAGTGGATTGCCTCCGGCAAGGAAAACCGCGCAGAAGACGCTCTG
AAAGTCAGCGCCGTTGATGCTGTTGTCACTGCTGACAAGCTGGGCGCAGCTGCCCTGGAC
CTGATCAAGCGCGCCATCAGTGGCGAACTGGACTACAAGGCCAAGCGTCAGCCGAAGCTG
GAAAAACTCAAGCTCAACGCTATCGAACAAATGATGGCTTTCGAAACCGCCAAAGGTTTC
GTGGCTGGCCAGGCCGGCCCGAACTACCCGGCCCCGGTTGAAGCGATCAAGACCATCCAG
AAAGCCGCGAACTTCGGTCGTGACAAAGCCCTGGAAGTGGAAGCTGCAGGTTTCGCCAAG
CTGGCCAAAACCAGCGCCTCGAACTGCCTGATCGGCCTGTTCCTGAACGATCAGGAACTG
AAGAAAAAGGCCAAGGTCTACGACAAGATCGCCAAAGACGTGAAGCAGGCCGCCGTTCTG
GGCGCCGGCATCATGGGTGGCGGCATTGCCTATCAGTCGGCGTCCAAAGGCACGCCGATC
CTGATGAAGGACATCAACGAGCACGGTATCGAGCAGGGCCTGGCTGAAGCCGCCAAGCTG
CTGGTAGGTCGCGTTGATAAAGGTCGCATGACCCCGGCAAAAATGGCTGAAGTGCTGAAC
GGCATTCGTCCTACTCTGTCCTACGGCGATTTCGGCAACGTCGACCTGGTGGTCGAAGCG
GTTGTCGAGAACCCGAAGGTCAAGCAGGCCGTGTTGGCGGAAGTGGAAAACCACGTTCGC
GAAGACGCCATCCTCGCTTCCAACACCTCGACCATTTCCATCAGCTTGCTGGCCAAGGCC
CTCAAGCGTCCGGAAAACTTCGTCGGCATGCACTTCTTCAACCCGGTACACATGATGCCG
CTGGTTGAAGTGATCCGTGGCGAGAAGTCCAGCGACCTGGCCGTGGCCACCACCGTTGCC
TACGCCAAGAAAATGGGCAAGAACCCGATCGTGGTCAACGACTGCCCGGGCTTCCTGGTC
AACCGCGTACTGTTCCCGTACTTCGGCGGTTTCGCCAAGCTGGTCAGCGCCGGTGTCGAC
TTTGTGCGTATCGACAAAGTGATGGAAAAATTCGGCTGGCCGATGGGCCCGGCGTACCTG
ATGGACGTGGTCGGTATCGACACTGGCCACCACGGTCGCGACGTGATGGCTGAAGGCTTC
CCGGACCGCATGAAAGACGACCGCCGCTCGGCGATCGATGCGCTGTACGAGGCCAAGCGC
CTGGGTCAGAAGAACGGCAAGGGCTTCTACGCCTACGAGGCTGACAAAAAGGGCAAGCAG
AAGAAACTGGTTGATTCGAGCGTGCTTGAAGTGCTCAAACCAATCGTTTACGAGCAGCGC
GACGTGACCGACGAAGACATCATCAACTGGATGATGATCCCGCTGTGCCTGGAAACCGTG
CGTTGCCTGGAAGACGGTATCGTTGAAACTGCAGCCGAGGCCGATATGGGCCTGGTCTAC
GGCATTGGCTTCCCGCTGTTCCGTGGTGGCGCGCTGCGCTACATCGATTCGATCGGTGTT
GCAGAGTTCGTCGCCCTGGCCGATCAGTACGCTGAACTGGGCGCGCTGTACCACCCGACT
GCGAAGCTGCGTGAGATGGCCAAGAACGGCCAGAGCTTCTTCGGTTAA

# Drug_Target_3_General_Function:
Lipid transport and metabolism

# Drug_Target_3_General_References:
1607366	Sato S, Hayashi M, Imamura S, Ozeki Y, Kawaguchi A: Primary structures of the genes, faoA and faoB, from Pseudomonas fragi B-0771 which encode the two subunits of the HDT multienzyme complex involved in fatty acid beta-oxidation. J Biochem. 1992 Jan;111(1):8-15.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6765

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
41605.7

# Drug_Target_3_Name:
3-ketoacyl-CoA thiolase

# Drug_Target_3_Number_of_Residues:
391

# Drug_Target_3_PDB_ID:
1WDM

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00108	Thiolase_N
PF02803	Thiolase_C

# Drug_Target_3_Protein_Sequence:
>3-ketoacyl-CoA thiolase
MSLNPRDVVIVDFGRTPMGRSKGGMHRNTRAEDMSAHLISKVLERNSKVDPGEVEDVIWG
CVNQTLEQGWNIARMASLMTQIPHTSAAQTVSRLCGSSMSALHTAAQAIMTGNGDVFVVG
GVEHMGHVSMMHGVDPNPHMSLYAAKASGMMGLTAEMLGKMHGISREQQDAFAVRSHQLA
HKATVEGKFKDEIIPMQGYDENGFLKIFDYDETIRPDTTLESLAALKPAFNPKGGTVTAG
TSSQITDGASCMIVMSAQRAKDLGLEPLAVIRSMAVAGVDPAIMGYGPVPATQKALKRAG
LNMADIDFIELNEAFAAQALPVLKDLKVLDKMNEKVNLHGGAIALGHPFGCSGARISGTL
LNVMKQNGGTFGLSTMCIGLGQGIATVFERV

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the final step of fatty acid oxidation in which acetyl-CoA is released and the CoA ester of a fatty acid two carbons shorter is formed (By similarity)

# Drug_Target_3_SwissProt_ID:
P28790

# Drug_Target_3_SwissProt_Name:
FADA_PSEFR

# Drug_Target_3_Synonyms:
Acetyl-CoA acyltransferase
Beta-ketothiolase
Fatty acid oxidation complex subunit beta

# Drug_Target_3_Theoretical_pI:
7.00

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cell outer membrane

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
L10210

# Drug_Target_4_GenBank_ID_Protein:
294361

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
fpvA

# Drug_Target_4_Gene_Sequence:
>2442 bp
ATGCCAGCACCACACGGTCTCAGTCCTCTGAGTAAGGCGTTTTTGATGCGCCGTGCCTTC
CAACGCAGGATTCTTCCCCACTCGCTCGCCATGGCCCTGAGCCTGCCGCTGGCGGGATAT
GTCCAGGCGCAGGAAGTCGAGTTCGACATCCCTCCCCAGGCGCTGGGCAGCGCACTCCAG
GAGTTCGGCCGCCAGGCGGATATCCAGGTGCTGTATCGCCCGGAAGAGGTCCGGAACAAG
CGTAGCAGTGCGATCAAGGGCAAGCTGGAGCCGAACCAGGCGATTACCGAGCTGCTTCGT
GGCACCGGCGCATCGGTGGACTTCCAGGGCAATGCGATAACCATCAGCGTCGCCGAGGCG
GCGGACAGCAGCGTCGATCTCGGCGCCACCATGATCACCTCCAACCAGTTGGGCACCATC
ACCGAGGACAGCGGCTCCTATACGCCAGGCACTATCGCCACGGCGACCCGCCTGGTCCTG
ACTCCGCGCGAGACGCCCCAGTCGATCACCGTGGTCACCCGCCAGAACATGGACGACTTC
GGCCTCAACAACATCGACGACGTCATGCGCCATACGCCGGGCATCACCGTCTCGGCCTAC
GACACTGACCGCAACAACTACTATGCCCGCGGCTTCTCGATCAACAACTTCCAGTACGAC
GGGATTCCCTCGACGGCCCGCAACGTCGGCTACTCCGCGGGCAATACGCTCAGTGACATG
GCCATCTACGACCGGGTGGAAGTACTCAAGGGGGCGACCGGCCTGCTCACCGGTGCGGGG
TCCCTCGGCGCCACGATCAACCTGATCCGCAAGAAACCTACCCATGAATTCAAGGGCCAT
GTCGAACTGGGCGCGGGCAGTTGGGACAATTACCGCTCCGAACTGGACGTCAGCGGCCCA
CTGACCGAGTCCGGCAACGTCCGCGGCCGGGCGGTAGCCGCCTACCAGGATAAGCACTCG
TTCATGGATCACTACGAGCGCAAAACCAGCGTCTATTACGGCATCCTCGAGTTCGATCTG
AATCCCGACACCATGCTTACCGTCGGCGCCGACTATCAGGACAACGATCCCAAGGGATCG
GGCTGGTCGGGCAGCTTCCCGCTCTTCGACAGCCAGGGCAACCGCAACGACGTCTCCCGC
TCCTTCAACAACGGAGCCAAGTGGAGCAGTTGGGAGCAGTACACCCGCACCGTCTTCGCC
AACCTCGAGCACAATTTCGCCAACGGCTGGGTCGGCAAGGTGCAACTCGATCACAAGATC
AACGGTTACCACGCGCCCCTCGGCGCGATCATGGGCGACTGGCCGGCACCGGACAACAGC
GCCAAGATCGTTGCGCAGAAGTACACCGGCGAAACCAAGAGCAACTCGCTGGATATCTAT
CTCACCGGCCCCTTCCAGTTCCTCGGTCGCGAGCACGAGCTGGTGGTCGGCACCTCGGCT
TCCTTCTCCCACTGGGAGGGCAAGAGCTACTGGAACCTGCGCAACTACGACAACACCACC
GACGACTTCATCAACTGGGACGGCGATATAGGCAAGCCCGACTGGGGTACCCCCTCCCAG
TACATCGATGACAAGACCCGCCAGTTGGGCAGCTACATGACCGCCCGCTTCAATGTGACC
GATGACCTGAACCTGTTCCTAGGTGGACGCGTGGTCGACTACCGGGTAACCGGCCTGAAT
CCGACCATTCGCGAGTCCGGACGCTTCATTCCCTACGTCGGCGCGGTCTACGACCTGAAC
GATACCTACTCCGTCTACGCCAGCTATACCGACATCTTCATGCCGCAGGACAGTTGGTAT
CGCGACAGCAGCAACAAGCTGCTCGAACCCGACGAAGGCCAGAACTACGAGATCGGCATC
AAGGGTGAATATCTCGACGGACGACTCAATACCAGTCTCGCCTACTTCGAGATTCATGAG
GAAAACCGCGCGGAGGAAGACGCCCTCTACAACAGCAAACCGACCAACCCCGCCATCACC
TACGCCTACAAGGGCATCAAGGCCAAGACCAAGGGCTACGAGGCGGAAATCTCGGGTGAA
CTGGCGCCAGGCTGGCAGGTTCAGGCTGGCTATACCCACAAGATCATTCGCGACGACAGT
GGCAAGAAGGTTTCCACCTGGGAGCCTCAGGACCAGTTGAGCCTCTTCACCAGCTACAAG
TTCAAGGGCGCCCTGGACAAGCTCACGGTCGGCGGCGGCGCCCGCTGGCAGGGCAAGAGC
TGGCAGATGGTCAATCCCCGCAGACGCTGGGAAAAGTTCTCCCAGGAAGACTACTGGCTG
GTGGACCTGATGGCCCGCTACCAGATCACCGACAAGCTGTCAGCCAGCGTCAACGTCAAC
AACGTCTTCGACAAGACCTACTACACCAACATCGGTTTCTACACCTCGGCATCCTATGGC
GATCCACGGAACCTGATGTTCAGCACTCGCTGGGACTTCTGA

# Drug_Target_4_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_4_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
8335619	Poole K, Neshat S, Krebes K, Heinrichs DE: Cloning and nucleotide sequence analysis of the ferripyoverdine receptor gene fpvA of Pseudomonas aeruginosa. J Bacteriol. 1993 Aug;175(15):4597-604.
8918232	McMorran BJ, Merriman ME, Rombel IT, Lamont IL: Characterisation of the pvdE gene which is required for pyoverdine synthesis in Pseudomonas aeruginosa. Gene. 1996 Oct 17;176(1-2):55-9.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2387

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
91168

# Drug_Target_4_Name:
Ferripyoverdine receptor

# Drug_Target_4_Number_of_Residues:
815

# Drug_Target_4_PDB_ID:
1XKH

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00593	TonB_dep_Rec
PF07660	STN
PF07715	Plug

# Drug_Target_4_Protein_Sequence:
>Ferripyoverdine receptor precursor
MPAPHGLSPLSKAFLMRRAFQRRILPHSLAMALSLPLAGYVQAQEVEFDIPPQALGSALQ
EFGRQADIQVLYRPEEVRNKRSSAIKGKLEPNQAITELLRGTGASVDFQGNAITISVAEA
ADSSVDLGATMITSNQLGTITEDSGSYTPGTIATATRLVLTPRETPQSITVVTRQNMDDF
GLNNIDDVMRHTPGITVSAYDTDRNNYYARGFSINNFQYDGIPSTARNVGYSAGNTLSDM
AIYDRVEVLKGATGLLTGAGSLGATINLIRKKPTHEFKGHVELGAGSWDNYRSELDVSGP
LTESGNVRGRAVAAYQDKHSFMDHYERKTSVYYGILEFDLNPDTMLTVGADYQDNDPKGS
GWSGSFPLFDSQGNRNDVSRSFNNGAKWSSWEQYTRTVFANLEHNFANGWVGKVQLDHKI
NGYHAPLGAIMGDWPAPDNSAKIVAQKYTGETKSNSLDIYLTGPFQFLGREHELVVGTSA
SFSHWEGKSYWNLRNYDNTTDDFINWDGDIGKPDWGTPSQYIDDKTRQLGSYMTARFNVT
DDLNLFLGGRVVDYRVTGLNPTIRESGRFIPYVGAVYDLNDTYSVYASYTDIFMPQDSWY
RDSSNKLLEPDEGQNYEIGIKGEYLDGRLNTSLAYFEIHEENRAEEDALYNSKPTNPAIT
YAYKGIKAKTKGYEAEISGELAPGWQVQAGYTHKIIRDDSGKKVSTWEPQDQLSLYTSYK
FKGALDKLTVGGGARWQGKSWQMVYNNPRSRWEKFSQEDYWLVDLMARYQITDKLSASVN
VNNVFDKTYYTNIGFYTSASYGDPRNLMFSTRWDF

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
1-43

# Drug_Target_4_Specific_Function:
Receptor for the siderophore ferripyoverdine

# Drug_Target_4_SwissProt_ID:
P48632

# Drug_Target_4_SwissProt_Name:
FPVA_PSEAE

# Drug_Target_4_Synonyms:
Ferripyoverdine receptor precursor

# Drug_Target_4_Theoretical_pI:
5.28

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB08249
